Cargando…

Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells

Detalles Bibliográficos
Autores principales:	Mateos-Jaimez, Judith, Mangolini, Maurizio, Vidal, Anna, Kulis, Marta, Colomer, Dolors, Campo, Elias, Ringshausen, Ingo, Martin-Subero, Jose I., Maiques-Diaz, Alba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249715/ https://www.ncbi.nlm.nih.gov/pubmed/37304935 http://dx.doi.org/10.1097/HS9.0000000000000909

Ejemplares similares

Bone Marrow Stromal Cells Drive Key Hallmarks of B Cell Malignancies
por: Mangolini, Maurizio, et al.
Publicado: (2020)

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9
por: Agudelo, Daniel, et al.
Publicado: (2020)

Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing
por: Chen, Yangcan, et al.
Publicado: (2022)

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
por: Sureda-Gómez, Marta, et al.
Publicado: (2022)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Bcl-2(high) mantle cell lymphoma cells are sensitized to acadesine with ABT-199
por: Montraveta, Arnau, et al.
Publicado: (2015)

Genome editing of immune cells using CRISPR/Cas9
por: Kim, Segi, et al.
Publicado: (2021)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

CRISPR/Cas9: A Robust Genome-Editing Tool with Versatile Functions and Endless Application
por: Zhang, Baohong
Publicado: (2020)

P1295: DECIPHERING THE ROLE OF MSI2 AS A REGULATOR OF MANTLE CELL LYMPHOMA STEM-LIKE PROPERTIES
por: Sureda-Gómez, M., et al.
Publicado: (2022)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1
por: Luo, Yufeng, et al.
Publicado: (2020)

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
por: Zhang, Xianming, et al.
Publicado: (2022)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Efficient CRISPR/Cas9-based genome editing in carrot cells
por: Klimek-Chodacka, Magdalena, et al.
Publicado: (2018)

Methods and applications of CRISPR/Cas system for genome editing in stem cells
por: Yang, Guang, et al.
Publicado: (2019)

How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
por: Johansen, Kristoffer Haurum
Publicado: (2022)

Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing
por: Tang, Xu, et al.
Publicado: (2019)

CRISPR/Cas9-Mediated Gene Editing in Salmonids Cells and Efficient Establishment of Edited Clonal Cell Lines
por: Strømsnes, Trygve A. H., et al.
Publicado: (2022)

Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape
por: Mangolini, Maurizio, et al.
Publicado: (2022)

Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes
por: Vicencio, Jeremy, et al.
Publicado: (2022)

Robust CRISPR/Cpf1 (Cas12a)‐mediated genome editing in allotetraploid cotton (Gossypium hirsutum)
por: Li, Bo, et al.
Publicado: (2019)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

High-Throughput Genotyping of CRISPR/Cas Edited Cells in 96-Well Plates
por: Nussbaum, Lea, et al.
Publicado: (2018)

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2020)

Efficient CRISPR/Cas9 genome editing with Citrus embryogenic cell cultures
por: Dutt, Manjul, et al.
Publicado: (2020)

CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
por: Morisaka, Hiroyuki, et al.
Publicado: (2019)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

Multiplex genome editing of microorganisms using CRISPR-Cas
por: Adiego-Pérez, Belén, et al.
Publicado: (2019)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qvv93n0oucl1lgp9j90sv7ic51